Enveric Biosciences (ENVB) Goodwill (2015 - 2023)

Enveric Biosciences has reported Goodwill for 9 years, with the latest figure at $253120.0 in Q3 2023.

• Quarterly Goodwill fell 82.76% year-over-year to $253120.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $253120.0 (down 82.76% YoY) and the FY2022 annual result came in at $379686.0, down 76.08% from the prior year.
• Goodwill retreated to $253120.0 in Q3 2023 per ENVB's latest filing, from $295311.0 in the prior quarter.
• Over five years, Goodwill peaked at $13.7 million in Q1 2019 and troughed at $253120.0 in Q3 2023.
• A 5-year average of $7.0 million and a median of $5.3 million in 2021 frame the typical range for Goodwill.
• The sharpest annual moves came in 2019 and 2022: Goodwill changed 0.0% in 2019, then plunged 83.8% in 2022.
• Over 5 years, Goodwill stood at $13.7 million in 2019, then changed by 0.0% to $13.7 million in 2020, then plunged by 88.44% to $1.6 million in 2021, then tumbled by 76.08% to $379686.0 in 2022, then slumped by 33.33% to $253120.0 in 2023.
• According to Business Quant data, Goodwill over the past three periods registered $253120.0, $295311.0, and $337498.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.